Murielle Thinard-McLane serves as COO for Genome Medical, Inc. Previously, she served as vice president and general manager of analytics for McKesson Specialty Health. In her role, she oversaw the development and implementation of McKesson oncology analytics strategy, helping physicians transition from fee for services to value based care.
Prior to that she was the VP and GM for generics and GPOs where she oversaw sourcing, contracting, pricing, financial planning and analysis, program development and management, and customer communications as well as McKesson biosimilars strategy. Ms. Thinard-McLane joined McKesson in 2009 to build the generics department, over her tenure, she has grown gross profit over six-fold and established the team as one of the main profit contributors. Prior to McKesson, Ms. Thinard-Mclane held a variety of positions in marketing, strategy and operations at a number of leading healthcare companies such as Novartis, Genentech, United Heath Group, and Chiron Corporation.
Ms. Thinard-McLane received a Master in finance from Universite of Lyon and an MBA from the Wharton School. She has been the recipient of 2010 McKesson President Award and of the 2008 Doctors of the World Health and Human Rights Leadership Award for her volunteer work on HIV/AIDs and TB in Cape Town with WHIVP.